tetano
Editor, Senior Moderator
Mayo Clin Proc
. 2020 Jun 16;S0025-6196(20)30482-1.
doi: 10.1016/j.mayocp.2020.05.009. Online ahead of print.
A Framework for Evidence Synthesis Programs to Respond to a Pandemic
M Hassan Murad[SUP] 1 [/SUP], Tarek Nayfeh[SUP] 2 [/SUP], Meritxell Urtecho Suarez[SUP] 2 [/SUP], Mohamed O Seisa[SUP] 2 [/SUP], Rami Abd-Rabu[SUP] 2 [/SUP], Magdoleen Hassan Eltayeb Farah[SUP] 2 [/SUP], Mohammed Firwana[SUP] 2 [/SUP], Bashar Hasan[SUP] 2 [/SUP], Tabinda Jawaid[SUP] 2 [/SUP], Sahrish Shah[SUP] 2 [/SUP], Victor Torres Roldan[SUP] 2 [/SUP], Larry Prokop[SUP] 2 [/SUP], Zhen Wang[SUP] 2 [/SUP], Samer Mohir Saadi[SUP] 2 [/SUP]
Affiliations
Abstract
The coronavirus disease 2019 (COVID-19) pandemic requires making rapid decisions based on sparse and rapidly changing evidence. Evidence synthesis programs conduct systematic reviews for guideline developers, health systems clinicians, and decision-makers that usually take an average 6 to 8 months to complete. We present a framework for evidence synthesis programs to respond to pandemics that has proven feasible and practical during the COVID-19 response in a large multistate health system employing more than 78,000 people. The framework includes four components: an approach for conducting rapid reviews, a repository of rapid reviews, a registry for all original studies about COVID-19, and twice-weekly prioritized update of new evidence sent to key stakeholders. As COVID-19 will not be our last pandemic, we share the details of this framework to allow replication in other institutions and re-implementation in future pandemics.
. 2020 Jun 16;S0025-6196(20)30482-1.
doi: 10.1016/j.mayocp.2020.05.009. Online ahead of print.
A Framework for Evidence Synthesis Programs to Respond to a Pandemic
M Hassan Murad[SUP] 1 [/SUP], Tarek Nayfeh[SUP] 2 [/SUP], Meritxell Urtecho Suarez[SUP] 2 [/SUP], Mohamed O Seisa[SUP] 2 [/SUP], Rami Abd-Rabu[SUP] 2 [/SUP], Magdoleen Hassan Eltayeb Farah[SUP] 2 [/SUP], Mohammed Firwana[SUP] 2 [/SUP], Bashar Hasan[SUP] 2 [/SUP], Tabinda Jawaid[SUP] 2 [/SUP], Sahrish Shah[SUP] 2 [/SUP], Victor Torres Roldan[SUP] 2 [/SUP], Larry Prokop[SUP] 2 [/SUP], Zhen Wang[SUP] 2 [/SUP], Samer Mohir Saadi[SUP] 2 [/SUP]
Affiliations
- PMID: 32561147
- DOI: 10.1016/j.mayocp.2020.05.009
Abstract
The coronavirus disease 2019 (COVID-19) pandemic requires making rapid decisions based on sparse and rapidly changing evidence. Evidence synthesis programs conduct systematic reviews for guideline developers, health systems clinicians, and decision-makers that usually take an average 6 to 8 months to complete. We present a framework for evidence synthesis programs to respond to pandemics that has proven feasible and practical during the COVID-19 response in a large multistate health system employing more than 78,000 people. The framework includes four components: an approach for conducting rapid reviews, a repository of rapid reviews, a registry for all original studies about COVID-19, and twice-weekly prioritized update of new evidence sent to key stakeholders. As COVID-19 will not be our last pandemic, we share the details of this framework to allow replication in other institutions and re-implementation in future pandemics.